Table 4.

Univariate and multivariate analysis of factors influencing hemostatic effectiveness.

Variables	Univariate OR (95% CI)	P-value	Multivariate OR (95% CI)	P-value
Age (years)
<48	Reference
≥48	1.335 (0.768-2.323)	0.306
FIGO stage
≤IIB	Reference		Reference
≥IIIA	0.443 (0.228-0.864)	0.017	0.333 (0.157-0.708)	0.004
Tissue differentiation
Well differentiated	Reference
Moderately differentiated	1.128 (0.521-2.441)	0.760
Poorly differentiated	0.750 (0.323-1.741)	0.504
Tumor location
outward	Reference
Inward	0.679 (0.351-1.313)	0.250
Mixed	0.932 (0.465-1.867)	0.843
Pathological type
Squamous cell carcinoma	Reference
Adenocarcinoma or Adenosquamous carcinoma	1.151 (0.500-2.648)	0.741
Maximum tumor diameter (cm)	0.997 (0.850-1.169)	0.969
HPV infection status
HPV16	Reference
HPV18	1.053 (0.460-2.412)	0.902
Other types	1.024 (0.551-1.905)	0.939
Hematological parameters
HB (g/L)	0.994 (0.981-1.007)	0.340
RBC (x10^12/L)	0.934 (0.629-1.386)	0.733
HCT (%)	0.981 (0.938-1.026)	0.398
PLT (x10^9/L)	0.998 (0.996-1.001)	0.149	0.999 (0.996-1.001)	0.298
Liver function
ALT (IU/L)	0.986 (0.969-1.002)	0.093	0.989 (0.969-1.008)	0.256
AST (IU/L)	0.995 (0.974-1.015)	0.604
ALB (g/L)	0.964 (0.908-1.024)	0.231
TBil (μmol/L)	1.033 (0.963-1.108)	0.365
Coagulation function
PT (s)	1.123 (0.840-1.500)	0.434
APTT (s)	1.004 (0.930-1.083)	0.924
TT (s)	1.053 (0.915-1.211)	0.472
FIB (g/L)	1.000 (0.744-1.342)	0.998
Blood loss volume (ml/d)
100-200	Reference		Reference
>200	0.631 (0.362-1.099)	0.104	0.551 (0.283-1.073)	0.079
Transfusion status
No	Reference		Reference
Yes	0.664 (0.377-1.172)	0.158	0.570 (0.281-1.157)	0.119
Urinary system obstruction
No	Reference
Yes	0.901 (0.472-1.719)	0.751
Treatment method
VP	Reference		Reference
PAE	11.449 (5.379-24.370)	<0.001	14.026 (6.343-31.015)	<0.001